|
Market Cap (24-Jun) $19,510,578 (1,113th) |
Close (30-Jun) $0.049 |
Volume (30-Jun) 1,094,468 |
Shortsold (12-Jul) 1 (0.00%) (672nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.45 |
EPS -0.02 |
PXS released this announcement to the ASX on 6 September 2022, 8:17. The announcement is not marked as price sensitive, and is 16 page(s) in length and 1.05MB in size.
You can view all announcements from PXS and see how they appear on a price chart on the announcements page.
At the date of this announcement, PXS was 0.000% short sold according to ASIC data. It was ranked the 672nd most shorted stock on the ASX. It remains ranked 672nd as of the latest reported data (12 July 2023).
| Other Recent Announcements from PXS | |
|---|---|
| Investor presentation | 24 May 2023, 8:21 |
| PXS Announces Encouraging Results from Phase 1c Scar Study | 23 May 2023, 16:32 |
| Trading Halt | 22 May 2023, 8:56 |
| Investor presentation | 6 September 2022, 8:17 |
| Application for quotation of securities - PXS | 1 September 2022, 9:58 |
| PXS to Receive Stg2.9m from Parkinsons UK for New Trial | 1 September 2022, 8:25 |
| Preliminary Final Report | 30 August 2022, 17:05 |
You must be logged in to post a reply.
Pharmaxis Ltd 